Provectus Pharmaceuticals Inc. to Use Numoda Corporation’s TruPoints System to Facilitate Transactions with Potential Licensing Partners for PH-10

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTC BB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, has signed an agreement with Numoda Capital Innovations LLC (http://www.numodacapital.com) to license its TruPoints® strategic partnering platform.